Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2009, Article ID 173439, 3 pages
http://dx.doi.org/10.1155/2009/173439
Case Report

Expansion of T Cells in an Immunocompetent Patient with Acute Toxoplasmosis

1Department of Hematology, Hospital San Pedro, Logroño, La Rioja 26006, Spain
2Department of Hematology, University Clinic, University of Navarra, 31008 Navarra, Spain
3Department of Microbiology, University Clinic, University of Navarra, 31008 Navarra, Spain
4Department of Immunology, University Clinic, University of Navarra, 31008 Navarra, Spain
5Department of Preventive Medicine and Public Health, University of Navarra, 31008 Navarra, Spain

Received 12 October 2008; Revised 12 May 2009; Accepted 16 June 2009

Academic Editor: Luigi Daniele Notarangelo

Copyright © 2009 R. García-Muñoz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

CD57 T cells increase in several viral infections like cytomegalovirus, herpesvirus, parvovirus, HIV and hepatitis C virus and are associated with several clinical conditions related to immune dysfunction and ageing. We report for the first time an expansion of CD8 CD57 T cells in a young patient with an acute infection with Toxoplasma gondii. Our report supports the concept that CD8 CD57 T cells could be important in the control of chronic phase of intracellular microorganisms and that the high numbers of these cells may reflect the continuing survey of the immune system, searching for parasite proliferation in the tissues.

1. Introduction

Toxoplasma gondii, an obligate intracellular protozoan, can invade and replicate in almost any nucleated host cell, being catsand their pray the definitive hosts. Oocysts shed in cat feces can infect a wide range of animals including humans. Infection occurs by ingestion of parasite-cyst-contaminated food or water; cysts rupture in the host, and the released parasites actively enter host cells [1]. Certain individuals are at high risk for severe disease, especially congenitally infected fetuses and newborns and immunologically impaired individuals [2]. Infection in immunocompetent hosts is usually asymptomatic and self-limited, and it does not normally require therapy [2]. Individuals infected with Toxoplasma gondii require a powerful immune response to contain dissemination of the parasite, resulting in a strong and persistent T-helper-1 (Th1) response characterised by production of proinflammatory cytokines including IL-12, INF- and TNF- [3]. Human CD4+ and CD8+ T lymphocytes are cytotoxic to Toxoplasma gondii-infected cells [4]. However, the possible implication of CD8+CD57+ T cells in the control of acute infection and the tissues survey in the chronic phase has never been described. We report a patient with acute toxoplasmosis with increased levels of CD8+CD57+ T cells in peripheral blood.

2. Case Report

A 20-year-old man presented with a 3-week history of fatigue and cervical lymphadenophaty. Chest X-ray was normal, but reactive laterocervical and jugulodigastric lymphadenophaties were found in cervical ultrasound. At presentation, peripheral blood count revealed a white blood cell count (WBC) of 5.9 109/L with 58.9 lymphocytes (3.5 /L) and absolute neutrophil count (ANC) of 29.7% ( ), and blood smear demonstrated the presence of numerous stimulated lymphocytes with intracytoplasmatic granules. Screening for infectious disease was performed including HIV, Epstein-Barr virus, cytomegalovirus, and Toxoplasma gondii. All results were negative except for positive IgM and IgG enzyme-linked immunosorbent assay to Toxoplasma gondii; the weakly IgG avidity test (low avidity) confirmed recent acquired infection. Flow cytometry analysis revealed an increase in the number of CD8+ T cells with a high grade of activation (67 expressed HLA-DR) and replicative senescence (49% expressed CD57); see Figure 1. Normal levels of CD4+ T cells and B cells were also observed (Table 1). The patient is currently asymptomatic and without treatment, with few nontender and discrete cervical lymph nodes.

tab1
Table 1: T cells, B cells, and NK cells counts by flow cytometry in whole peripheral blood.
fig1
Figure 1: Increased number of CD8+ T cells with a high grade of activation (HLA-DR) and replicative senescence (CD57+).

3. Discussion

CD57+ T lymphocytes are virtually absent at birth [5] and progressively increasing with age [6]. CD8+CD57+ T cells increases in chronic immune activation states and in infectious diseases like HIV [7], tuberculosis [8], and some virus, particularly cytomegalovirus [9, 10]. However, increased numbers of these cells in toxoplasmosishave never been reported before. Interestingly, INF-gamma production is directly correlated with CD8+CD28-CD57+ T cells and age [11]. More over, IFN-gamma is crucial in protective immunity against Toxoplasma gondii infection, and CD8+CD57+ T cells can proliferate and produce high amounts of INF-gamma and IL-5 [12]. Both cytokines are related with a protective role against Toxoplasma gondii infection [13]. Taken together, is possible that CD8+CD57+ T cells could prevent the reactivation of old intruders that cannot be cleared in the young age, in particular CMV [9] and Toxoplasma gondii infections. We suggest that CD8+CD57+ T prevent the reactivation of Toxoplasma gondii in a similar manner that CD8+CD57+ T cells can control CMV reactivation in elderly individuals.

References

  1. J. Aliberti, “Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii,” Nature Reviews Immunology, vol. 5, no. 2, pp. 162–170, 2005. View at Publisher · View at Google Scholar
  2. J. G. Montoya and O. Liesenfeld, “Toxoplasmosis,” The Lancet, vol. 363, no. 9425, pp. 1965–1976, 2004. View at Publisher · View at Google Scholar
  3. P. J. Gaddi and G. S. Yap, “Cytokine regulation of immunopathology in toxoplasmosis,” Immunology and Cell Biology, vol. 85, no. 2, pp. 155–159, 2007. View at Publisher · View at Google Scholar
  4. J. G. Montoya, K. E. Lowe, C. Clayberger et al., “Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells,” Infection and Immunity, vol. 64, no. 1, pp. 176–181, 1996. View at Google Scholar
  5. E. de Vries, S. de Bruin-Versteeg, W. M. Comans-Bitter et al., “Longitudinal survey of lymphocyte subpopulations in the first year of life,” Pediatric Research, vol. 47, no. 4, pp. 528–537, 2000. View at Google Scholar
  6. S. Vasto, G. Colonna-Romano, A. Larbi, A. Wikby, C. Caruso, and G. Pawelec, “Role of persistent CMV infection in configuring T cell immunity in the elderly,” Immunity and Ageing, vol. 4, p. 2, 2007. View at Publisher · View at Google Scholar
  7. Y. Le Priol, D. Puthier, C. Lécureuil et al., “High cytotoxic and specific migratory potencies of senescent CD8+CD57+ cells in HIV-infected and uninfected individuals,” The Journal of Immunology, vol. 177, no. 8, pp. 5145–5154, 2006. View at Google Scholar
  8. I. Sada-Ovalle, L. Torre-Bouscoulet, R. Valdez-Vazquez, S. Martinez-Cairo, E. Zenteno, and R. Lascurain, “Characterization of a cytotoxic CD57+ T cell subset from patients with pulmonary tuberculosis,” Clinical Immunology, vol. 121, no. 3, pp. 314–323, 2006. View at Publisher · View at Google Scholar
  9. R. D. Kovaiou, B. Weinberger, and B. Grubeck-Loebenstein, “Aging and the immune system,” in Clinical Immunology Principles and Practice, R. R. Rich, T. A. Fleisher, W. T. Shearer, H. W. Schroeder Jr., A. J. Frew, and C. M. Weyland, Eds., pp. 739–747, Mosby Elsevier, St. Louis, Miss, USA, 3rd edition, 2008. View at Google Scholar
  10. N. Khan, A. Hislop, N. Gudgeon et al., “Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection,” The Journal of Immunology, vol. 173, p. 7481, 2004. View at Google Scholar
  11. E. Bandrés, J. Merino, B. Vázquez et al., “The increase of IFN-? production through aging correlates with the expanded CD8+highCD28-CD57+ subpopulation,” Clinical Immunology, vol. 96, no. 3, pp. 230–235, 2000. View at Publisher · View at Google Scholar
  12. L. K. Chong, R. J. Aicheler, S. Llewellyn-Lacey, P. Tomasec, P. Brennan, and E. C. Y. Wang, “Proliferation and interleukin 5 production by CD8hiCD57+ T cells,” European Journal of Immunology, vol. 38, no. 4, pp. 995–1000, 2008. View at Publisher · View at Google Scholar
  13. Y. Zhang and E. Y. Denkers, “Protective role for interleukin-5 during chronic Toxoplasma gondii infection,” Infection and Immunity, vol. 67, no. 9, pp. 4383–4392, 1999. View at Google Scholar